Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Tirschwell

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
Stroke|January 24, 2013
Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapyW T Longstreth, Richard A Kronmal, John L P Thompson, et al.
Neurology|April 4, 2023
Plasma Proteomic Associations With Incident Ischemic Stroke in Older Adults: The Cardiovascular Health StudyRizwan Kalani, Traci M Bartz, Bruce M Psaty, et al.
Neurocritical Care|June 28, 2018
Minority Patients are Less Likely to Undergo Withdrawal of Care After Spontaneous Intracerebral HemorrhageCora H Ormseth, Guido J Falcone, Sara D Jasak, et al.
Annals of Neurology|February 25, 2026
Apixaban Versus Aspirin and Risk of Hemorrhage in the ARCADIA TrialHooman Kamel, W T Longstreth, David L Tirschwell, et al.
Stroke|May 26, 2012
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke AssociationDaniel T Lackland, Mitchell S V Elkind, Ralph D'Agostino, et al.
Journal of the American Heart Association|July 29, 2025
Heart Rhythm Monitoring Practices, Detection of Atrial Fibrillation, and Effect of Anticoagulation in the ARCADIA TrialHooman Kamel, Mitchell S V Elkind, Richard A Kronmal, et al.
Stroke|August 5, 2021
Clinical Performance Measures for Stroke Rehabilitation: Performance Measures From the American Heart Association/American Stroke AssociationJoel Stein, Douglas I Katz, Randie M Black Schaffer, et al.
European Stroke Journal|August 30, 2024
Atrial cardiopathy biomarkers and atrial fibrillation in the ARCADIA trialHooman Kamel, Mitchell Sv Elkind, Richard A Kronmal, et al.
Stroke|December 5, 2025
Multiterritory Brain Infarcts, Anticoagulation, and Recurrence After Cryptogenic Stroke: A Subgroup Analysis of the ARCADIA TrialRachel Gologorsky, Maarten G Lansberg, Max Wintermark, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 11, 2018
The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methodsHooman Kamel, W T Longstreth, David L Tirschwell, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Stroke|January 24, 2013
Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapyW T Longstreth, Richard A Kronmal, John L P Thompson, et al.
Neurology|April 4, 2023
Plasma Proteomic Associations With Incident Ischemic Stroke in Older Adults: The Cardiovascular Health StudyRizwan Kalani, Traci M Bartz, Bruce M Psaty, et al.
Neurocritical Care|June 28, 2018
Minority Patients are Less Likely to Undergo Withdrawal of Care After Spontaneous Intracerebral HemorrhageCora H Ormseth, Guido J Falcone, Sara D Jasak, et al.
Annals of Neurology|February 25, 2026
Apixaban Versus Aspirin and Risk of Hemorrhage in the ARCADIA TrialHooman Kamel, W T Longstreth, David L Tirschwell, et al.
Stroke|May 26, 2012
Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke AssociationDaniel T Lackland, Mitchell S V Elkind, Ralph D'Agostino, et al.
Journal of the American Heart Association|July 29, 2025
Heart Rhythm Monitoring Practices, Detection of Atrial Fibrillation, and Effect of Anticoagulation in the ARCADIA TrialHooman Kamel, Mitchell S V Elkind, Richard A Kronmal, et al.
Stroke|August 5, 2021
Clinical Performance Measures for Stroke Rehabilitation: Performance Measures From the American Heart Association/American Stroke AssociationJoel Stein, Douglas I Katz, Randie M Black Schaffer, et al.
European Stroke Journal|August 30, 2024
Atrial cardiopathy biomarkers and atrial fibrillation in the ARCADIA trialHooman Kamel, Mitchell Sv Elkind, Richard A Kronmal, et al.
Stroke|December 5, 2025
Multiterritory Brain Infarcts, Anticoagulation, and Recurrence After Cryptogenic Stroke: A Subgroup Analysis of the ARCADIA TrialRachel Gologorsky, Maarten G Lansberg, Max Wintermark, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|September 11, 2018
The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methodsHooman Kamel, W T Longstreth, David L Tirschwell, et al.
Pageof 12